Biogen Profit Beats Street Estimates as Cost-Cutting Takes Hold
Biogen Inc. reported first-quarter profit that beat Wall Street’s expectations as the biotech giant’s new Alzheimer’s drug Leqembi gained traction and cost cuts took hold.
Biogen Inc. reported first-quarter profit that beat Wall Street’s expectations as the biotech giant’s new Alzheimer’s drug Leqembi gained traction and cost cuts took hold.
Orange SA’s revenue recovery in its home market of France, the telecommunications company’s biggest, was dampened by broadband customer defections in the first quarter.
After more than a year’s respite from record price swings in Europe’s natural gas market, traders are getting agitated again.
Iceland’s inflation eased to the slowest pace in more than two years, suggesting its central bank is more likely to begin reducing the western Europe’s highest interest rate in the coming months.
The second plug-in from the Italian carmaker packs nearly 800 horsepower and lots of attitude.
{{ video.ContentPackages[0].ScheduleStartDateTime | fromNow }}
{{ currentStream.Desc }}